CN101531993A - 稳定荧光标记细胞核的方法和试剂盒 - Google Patents
稳定荧光标记细胞核的方法和试剂盒 Download PDFInfo
- Publication number
- CN101531993A CN101531993A CN 200810084602 CN200810084602A CN101531993A CN 101531993 A CN101531993 A CN 101531993A CN 200810084602 CN200810084602 CN 200810084602 CN 200810084602 A CN200810084602 A CN 200810084602A CN 101531993 A CN101531993 A CN 101531993A
- Authority
- CN
- China
- Prior art keywords
- cell
- quantum dot
- dapi
- fluorescence
- nucleus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 48
- 238000002372 labelling Methods 0.000 title claims abstract description 8
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 claims abstract description 56
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 29
- 238000012360 testing method Methods 0.000 claims abstract description 16
- 210000004027 cell Anatomy 0.000 claims description 155
- 239000002096 quantum dot Substances 0.000 claims description 90
- 210000004940 nucleus Anatomy 0.000 claims description 61
- 230000005284 excitation Effects 0.000 claims description 23
- 239000012472 biological sample Substances 0.000 claims description 21
- 238000005406 washing Methods 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 7
- 239000007853 buffer solution Substances 0.000 claims description 5
- 244000309466 calf Species 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 3
- 239000012930 cell culture fluid Substances 0.000 claims description 2
- 210000003855 cell nucleus Anatomy 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims description 2
- 239000004065 semiconductor Substances 0.000 abstract description 6
- 230000007774 longterm Effects 0.000 abstract description 5
- 238000011160 research Methods 0.000 abstract description 5
- 238000001215 fluorescent labelling Methods 0.000 abstract description 4
- 239000002086 nanomaterial Substances 0.000 abstract description 2
- 238000011835 investigation Methods 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 21
- 239000006059 cover glass Substances 0.000 description 18
- 230000008859 change Effects 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 12
- 239000012530 fluid Substances 0.000 description 10
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 9
- 241000594182 Sarcophaga sigma Species 0.000 description 8
- 238000013016 damping Methods 0.000 description 8
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 201000004101 esophageal cancer Diseases 0.000 description 7
- 238000003384 imaging method Methods 0.000 description 7
- 238000012633 nuclear imaging Methods 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229910002091 carbon monoxide Inorganic materials 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 201000005619 esophageal carcinoma Diseases 0.000 description 6
- 238000005286 illumination Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000013611 chromosomal DNA Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- AQCDIIAORKRFCD-UHFFFAOYSA-N cadmium selenide Chemical compound [Cd]=[Se] AQCDIIAORKRFCD-UHFFFAOYSA-N 0.000 description 4
- 230000009194 climbing Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 230000002427 irreversible effect Effects 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 3
- 229930040373 Paraformaldehyde Natural products 0.000 description 3
- 108010039918 Polylysine Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 210000004691 chief cell of stomach Anatomy 0.000 description 3
- PTKRHFQQMJPPJN-UHFFFAOYSA-N dipotassium;oxido-(oxido(dioxo)chromio)oxy-dioxochromium;sulfuric acid Chemical compound [K+].[K+].OS(O)(=O)=O.[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O PTKRHFQQMJPPJN-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002073 fluorescence micrograph Methods 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 201000002528 pancreatic cancer Diseases 0.000 description 3
- 208000008443 pancreatic carcinoma Diseases 0.000 description 3
- 229920002866 paraformaldehyde Polymers 0.000 description 3
- 229920000656 polylysine Polymers 0.000 description 3
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 201000009030 Carcinoma Diseases 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 238000012151 immunohistochemical method Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 210000002220 organoid Anatomy 0.000 description 2
- 238000005424 photoluminescence Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- -1 EB) and derivative Chemical compound 0.000 description 1
- 101150029707 ERBB2 gene Proteins 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010061523 Lip and/or oral cavity cancer Diseases 0.000 description 1
- 206010062038 Lip neoplasm Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000032271 Malignant tumor of penis Diseases 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 208000009869 Neu-Laxova syndrome Diseases 0.000 description 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 208000002471 Penile Neoplasms Diseases 0.000 description 1
- 206010034299 Penile cancer Diseases 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000033781 Thyroid carcinoma Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 201000003761 Vaginal carcinoma Diseases 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- 239000005083 Zinc sulfide Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- VSTHNGLPHBTRMB-UHFFFAOYSA-N acridine orange Chemical compound [H+].[Cl-].C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 VSTHNGLPHBTRMB-UHFFFAOYSA-N 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 208000022033 carcinoma of urethra Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 201000000787 conjunctival cancer Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 230000007457 establishment of nucleus localization Effects 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 201000001343 fallopian tube carcinoma Diseases 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 201000010175 gallbladder cancer Diseases 0.000 description 1
- 201000007487 gallbladder carcinoma Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 201000006721 lip cancer Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 239000013335 mesoporous material Substances 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 210000000463 red nucleus Anatomy 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229910001753 sapphirine Inorganic materials 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- DRDVZXDWVBGGMH-UHFFFAOYSA-N zinc;sulfide Chemical compound [S-2].[Zn+2] DRDVZXDWVBGGMH-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810084602 CN101531993B (zh) | 2008-03-12 | 2008-03-12 | 稳定荧光标记细胞核的方法和试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810084602 CN101531993B (zh) | 2008-03-12 | 2008-03-12 | 稳定荧光标记细胞核的方法和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101531993A true CN101531993A (zh) | 2009-09-16 |
CN101531993B CN101531993B (zh) | 2013-05-29 |
Family
ID=41102859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810084602 Expired - Fee Related CN101531993B (zh) | 2008-03-12 | 2008-03-12 | 稳定荧光标记细胞核的方法和试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101531993B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104597114A (zh) * | 2015-01-21 | 2015-05-06 | 华中师范大学 | 高分辨质谱仪负离子模式低质量区的质量校正试剂盒及校正方法 |
US20150185182A1 (en) * | 2013-10-03 | 2015-07-02 | Biotium, Inc. | Nucleic acid binding dyes with improved safety |
CN107576787A (zh) * | 2017-08-17 | 2018-01-12 | 上海大学 | 荧光标记细胞核用试剂盒及其标记方法 |
CN108267432A (zh) * | 2017-12-19 | 2018-07-10 | 宁夏医科大学总医院 | 一种在脊髓损伤鼠模型中示踪移植的嗅鞘细胞的方法 |
CN110412002A (zh) * | 2019-08-08 | 2019-11-05 | 中山大学孙逸仙纪念医院 | 一种鉴别人源细胞和小鼠源细胞的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100501402C (zh) * | 2005-12-20 | 2009-06-17 | 武汉大学 | 一种稳定标记肝癌细胞的方法 |
-
2008
- 2008-03-12 CN CN 200810084602 patent/CN101531993B/zh not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150185182A1 (en) * | 2013-10-03 | 2015-07-02 | Biotium, Inc. | Nucleic acid binding dyes with improved safety |
US10011570B2 (en) * | 2013-10-03 | 2018-07-03 | Biotium, Inc. | Nucleic acid binding dyes with improved safety |
CN104597114A (zh) * | 2015-01-21 | 2015-05-06 | 华中师范大学 | 高分辨质谱仪负离子模式低质量区的质量校正试剂盒及校正方法 |
CN104597114B (zh) * | 2015-01-21 | 2016-03-30 | 华中师范大学 | 高分辨质谱仪负离子模式低质量区的质量校正试剂盒及校正方法 |
CN107576787A (zh) * | 2017-08-17 | 2018-01-12 | 上海大学 | 荧光标记细胞核用试剂盒及其标记方法 |
CN107576787B (zh) * | 2017-08-17 | 2020-06-05 | 上海大学 | 荧光标记细胞核用试剂盒及其标记方法 |
CN108267432A (zh) * | 2017-12-19 | 2018-07-10 | 宁夏医科大学总医院 | 一种在脊髓损伤鼠模型中示踪移植的嗅鞘细胞的方法 |
CN110412002A (zh) * | 2019-08-08 | 2019-11-05 | 中山大学孙逸仙纪念医院 | 一种鉴别人源细胞和小鼠源细胞的方法 |
CN110412002B (zh) * | 2019-08-08 | 2022-01-11 | 中山大学孙逸仙纪念医院 | 一种鉴别人源细胞和小鼠源细胞的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101531993B (zh) | 2013-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Qiao et al. | Signal transduction from small particles: Sulfur nanodots featuring mercury sensing, cell entry mechanism and in vitro tracking performance | |
Kozma et al. | Fluorogenic probes for super-resolution microscopy | |
Du et al. | Hydrothermal synthesis and application of Ho3+-activated NaYbF4 bifunctional upconverting nanoparticles for in vitro cell imaging and latent fingerprint detection | |
CN107922834B (zh) | 用具有aie特性的荧光光稳定线粒体特异生物探针实时监测线粒体自噬过程 | |
Weng et al. | Luminescent quantum dots: a very attractive and promising tool in biomedicine | |
Wang et al. | In vitro and in vivo imaging with quantum dots | |
Wu et al. | Doped quantum dots for chemo/biosensing and bioimaging | |
Song et al. | Low molecular weight fluorescent probes with good photostability for imaging RNA-rich nucleolus and RNA in cytoplasm in living cells | |
Byers et al. | Quantum dots brighten biological imaging | |
Gill et al. | A ruthenium (II) polypyridyl complex for direct imaging of DNA structure in living cells | |
Rizvi et al. | Near-infrared quantum dots for HER2 localization and imaging of cancer cells | |
Cserép et al. | Bioorthogonal fluorescent labels: a review on combined forces | |
CN101531993B (zh) | 稳定荧光标记细胞核的方法和试剂盒 | |
Wang et al. | Synthesis and characterization of water-soluble polythiophene derivatives for cell imaging | |
Koteeswari et al. | Highly selective, sensitive and quantitative detection of Hg 2+ in aqueous medium under broad pH range | |
Kim et al. | Near-infrared lipophilic fluorophores for tracing tissue growth | |
US9410958B2 (en) | Alkyne-activated fluorogenic azide compounds and methods of use thereof | |
Stockhammer et al. | Appreciating the small things in life: STED microscopy in living cells | |
Kong et al. | Two-photon induced responsive f–f emissive detection of Cyclin A with a europium-chelating peptide | |
Liu et al. | A series of carbazole cationic compounds with large two-photon absorption cross sections for imaging mitochondria in living cells with two-photon fluorescence microscopy | |
WO2010096720A2 (en) | Methods and compositions for altering photophysical properties of fluorophores via proximal quenching | |
Yuan et al. | Labeling thiols on proteins, living cells and tissues with enhanced emission induced by FRET | |
Duan et al. | A membrane permeable fluorescent Ca 2+ probe based on bis-BODIPY with branched PEG | |
Vibin et al. | Effective cellular internalization of silica-coated CdSe quantum dots for high contrast cancer imaging and labelling applications | |
Algar | Heroes or villains? How nontraditional luminescent materials do and do not enhance bioanalysis and imaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150914 Address after: 100021 Beijing, Panjiayuan, South Lane, No. 17, No. Patentee after: CANCER HOSPITAL, CHINESE ACEDEMY OF MEDICAL SCIENCES Patentee after: PLA NAVY GENERAL HOSIPTAL Address before: 100021 Beijing, Panjiayuan, South Lane, No. 17, No. Patentee before: CANCER INSTITUTE, CHINESE ACADEMY OF MEDICAL SCIENCES Patentee before: PLA NAVY GENERAL HOSIPTAL |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130529 |